Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Gammagard

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



Living with dementia

living with dementia1 - mental exercises1 - sleep1 - prevent dementia4 - development of parkinson's1 - dementia care program1 - visuospatial deficits1 - play-up programme1 - cortical atrophy1 - synthetic tau fibrils1 - icd-101 - csf1 - preparing for appointment1 - cognitive ability1 - parkinson's disease protein1 - carl schneider1 - alzheimer's patient1 - thiamin deficiency1 - cause of dementia5 - rheumatoid arthritis1 - late-day anxiety1 - alzheimer’s patients1 - functional activation studies1 - biomarkers of alzheimer's disease1 - phosphorylated alpha-synuclein1 - blood markers1 - alzheimer society1 - dementia types1 - wernicke's syndrome10 - blood test1 -